Anesthesia and analgesia
-
Anesthesia and analgesia · Sep 1997
Randomized Controlled Trial Clinical TrialOptimal dose of granisetron for prophylaxis against postoperative emesis after gynecological surgery.
We previously reported that 20 and 40 microg/kg of granisetron given during anesthesia prevented postoperative emesis with no severe complications. The aim of the current study was to determine the optimal dose of granisetron for the prevention of postoperative nausea and vomiting (PONV) after gynecological surgery. Two hundred female patients (ASA physical status I) were randomly allocated to one of five groups (n = 40 for each): saline (as a control), granisetron 2 microg/kg, granisetron 5 microg/kg, granisetron 10 microg/kg, and granisetron 20 microg/kg. Saline or granisetron was given intravenously immediately after induction of anesthesia. PONV was assessed 24 h after surgery. The percentage of emesis-free patients was significantly greater in the 5- to 20-microg/kg granisetron groups than in the control and 2-microg/kg granisetron groups (18%, 23%, 68%, 78%, and 75% of patients receiving saline or granisetron 2 microg/kg, 5 microg/kg, 10 microg/kg, and 20 microg/kg, respectively). Granisetron doses of 5 microg/kg or larger were also superior to the saline and 2-microg/kg granisetron treatment for the prevention of nausea over the 24-h study period (nausea visual analog scales 24 h after surgery: 49, 41, 18, 16, and 14 mm in the control and granisetron 2 microg/kg, 5 microg/kg, 10 microg/kg, and 20 microg/kg groups, respectively). A smaller proportion of patients received "rescue" antiemetic in the 5-microg/kg or larger granisetron groups than in the control and 2-microg/kg granisetron groups (48%, 40%, 18%, 13%, and 10% of patients in the control and granisetron 2 microg/kg, 5 microg/kg, 10 microg/kg, and 20 microg/kg groups, respectively). The antiemetic effect of granisetron was similar among the groups who received 5-microg/kg or larger doses. In conclusion, we suggest that the optimal dose of granisetron is 5 microg/kg for the prevention of PONV after gynecological surgery. ⋯ Nausea and vomiting postoperatively after gynecologic surgery is a significant problem. The authors found that granisetron, a selective antagonist of serotonin, markedly decreases the incidence of postoperative nausea and vomiting at doses of 5 microg/kg or larger.
-
Anesthesia and analgesia · Sep 1997
Comparative StudyDose-response and time course of effect of rocuronium in male and female anesthetized patients.
To determine differences from dose-response and time-course of rocuronium between male and female patients, 60 adult patients (30 male and 30 female), ASA grade I, aged 17-52 yr, undergoing elective plastic surgery were studied. Anesthesia was maintained with 60% nitrous oxide in oxygen, thiopental, and incremental doses of fentanyl as required. Neuromuscular function was assessed mechanomyographically with train-of-four (TOF) stimulation at the wrist every 12 s, and the percentage depression of the T1 response was used as the study variable. The dose-response relationship of rocuronium was determined by a cumulative dose-response technique. The results showed that the dose-response curve of rocuronium in the men was shifted to the right, indicating a decrease in the sensitivity to rocuronium-induced neuromuscular block versus the women. The 50%, 90%, and 95% effective doses of rocuronium were 178.4 +/- 53.7, 358.7 +/- 101.3, and 386.2 +/- 113.4 microg/kg, respectively, in male patients, and 128.8 +/- 42.5, 252.8 +/- 51.7, and 274.4 +/- 59.4 microg/kg in female patients. After an intravenous administration of total dose of 400 microg/kg rocuronium, neuromuscular block was significantly longer in the men than in the women. The duration of peak effect, clinical duration, and total duration were 6.5 +/- 3.0, 12.5 +/- 4.9, and 33.6 +/- 8.7 min, respectively, in male patients, and 11.8 +/- 2.7, 18.5 +/- 5.3, and 46.8 +/- 9.6 min in female patients. We conclude that women were approximately 30% more sensitive to rocuronium compared with men. ⋯ The authors found that women were 30% more sensitive to rocuronium than men. This suggests that the routine dose of rocuronium should be reduced in women compared with men.
-
Anesthesia and analgesia · Sep 1997
Randomized Controlled Trial Clinical TrialSimulation of an epidural test dose with intravenous isoproterenol in isoflurane-anesthetized adults.
Although a simulated intravenous (I.V.) test dose containing 3 microg isoproterenol results in a reliable heart rate (HR) increase in anesthetized patients, hypotension may limit its clinical utility. The present study was designed to determine the incidence of hypotension and the reliability of smaller doses of isoproterenol. Forty-five healthy adult patients were anesthetized with 1% end-tidal isoflurane and nitrous oxide after endotracheal intubation and were randomized to one of three groups according to the dose of isoproterenol. Isoproterenol 1-, 2-, and 3-microg groups (n = 15 each) received 3 mL of 1.5% lidocaine with 1, 2, and 3 microg isoproterenol I.V., respectively, to simulate an intravascularly administered test dose. HR and systolic blood pressure were measured at 20-s intervals for 4 min after injection. Mean maximal HR increases were 15 +/- 6, 23 +/- 10, and 32 +/- 7 bpm (mean +/- SD) in the isoproterenol 1-, 2-, and 3-microg groups, respectively. However, the incidence and degree of systolic hypotension were similar among groups. Isoproterenol 3 microg produced 100% sensitivity in both the conventional (> or = 20 bpm increase) and the modified (> or = 10 bpm increase) HR criteria, but 2 microg resulted in 100% sensitivity on the modified criterion alone. Isoproterenol 1 microg did not elicit reliable HR changes. Significant correlation was demonstrated between the isoproterenol dose (microg/kg) and the maximal HR increase. Ninety-five percent confidence intervals to increase HR by 10 and 20 bpm were 0.015-0.02 microg/kg and 0.03-0.04 microg/kg, respectively. The application of isoproterenol as a test dose component seems promising, pending detailed studies of neural toxicity. The appropriate dose needs to be tailored according to the patient's weight. ⋯ To determine whether an epidural catheter may be in a blood vessel, various vasoactive drugs are often administered. The author found that isoproterenol might be a useful drug in place of epinephrine.
-
Anesthesia and analgesia · Sep 1997
Comparative StudyContinuous cardiac output monitoring during adult liver transplantation: thermal filament technique versus bolus thermodilution.
Continuous thermodilution (CT) using a pulmonary artery (PA) catheter with a thermal filament has the potential for intraoperative on-line monitoring of cardiac output. Liver transplantation frequently requires rapid fluid administration and often includes the use of an extracorporeal veno-venous bypass. To assess the agreement between CT and bolus thermodilution (BT) in such a setting, we conducted a prospective intraoperative study in 14 liver transplant patients. Throughout the operation, CT cardiac output was recorded and paired with BT measurements taken every 30 min and whenever indicated for clinical reason. Corresponding data were assigned to acquisition periods when patients were on or off veno-venous bypass (flow rate 2.5 +/- 0.2 L/min) and were discriminated by the various range of intravenous infusion rates (< 150 mL/h, 150-1000 mL/h, 1000-2000 mL/h, and 2000-4000 mL/h) and the magnitude of cardiac output (< or = 7.5 L/min, 7.5-10.0 L/min, > 10.0 L/min). A total of 270 data pairs was obtained and examined by analysis of agreement (mean difference +/- SD), variance, error, and weighted regression. Trend analysis was performed for significant CT and BT cardiac output changes, defined as changes greater than 15%. Agreement of both methods was best at peripheral intravenous fluid infusion rates < or = 1000 mL/h and BT cardiac output > 10 L/min (0.0 +/- 0.6 L/min) and was unaffected by veno-venous bypass. Discrepancy was most evident at intravenous fluid infusion rates > 2000 mL/h and BT cardiac output < or = 7.5 L/min (2.1 +/- 1.7 L/min). Correlation of CT and BT cardiac output was excellent (r = 0.95, P < 0.001) for combined data from all patients. Changes in CT cardiac output > 15% (n = 116) correctly indicated the direction in 93% of BT cardiac output changes and were 74% sensitive and 75% specific for significant BT cardiac output changes. The thermal filament technique enhances the usefulness of PA catheterization during liver transplantation but reflects BT cardiac output with clinically acceptable error only at low peripheral intravenous fluid infusion rates. ⋯ Cardiac output determines organ perfusion. In clinical practice, it is measured by intermittent thermodilution using right heart catheterization. This intraoperative study compared the intermittent method with a technique based on continuous thermodilution. The new technique provides logistical advantages and challenges the accuracy of the intermittent method during liver transplantation.
-
Anesthesia and analgesia · Sep 1997
Comparative StudyThe effect of priming with vecuronium and rocuronium on young and elderly patients.
The priming principle consists of administering a subparalyzing dose of nondepolarizing neuromuscular blocking drug 3-6 min before giving a second dose for tracheal intubation. This study was performed to observe the effects of priming doses of vecuronium and rocuronium on pulmonary function tests and muscular weaknesses in young (25-35 yr of age) and elderly (65-73 yr of age) patients. Ten young and 10 elderly patients were each placed in vecuronium and rocuronium groups. Oxygen saturation and train-of-four (TOF) ratio were determined, and pulmonary function tests were performed. Then 20% of the 95% effective dose (ED95) of the muscle relaxants was given intravenously. All tests were performed again 4 min after vecuronium and 3 min after rocuronium. Other signs of muscular weaknesses were also recorded. Elderly patients showed more signs of muscle weakness in both groups. The TOF ratio was 0.77 and 0.79 in the elderly rocuronium and vecuronium groups, respectively, and 0.89 and 0.90 in the young rocuronium and vecuronium groups, respectively. Dynamic spirometry revealed decreases in forced expiratory volume in 1 s and forced vital capacity in both groups, and no significant changes in peak expiratory flow rate. The expiratory reserve volume was reduced more in the elderly groups. Oxygen saturation decreased in both groups. We conclude that oxygen saturation, pulmonary function, and muscle strength decrease more in the elderly than in their younger counterparts from priming doses of vecuronium or rocuronium. ⋯ The priming principle consists of giving a subparalyzing dose of muscle relaxant 3-6 min before giving a second dose for tracheal intubation. We found that priming doses of vecuronium and rocuronium produced greater decreases in oxygen saturation and pulmonary function in the elderly (aged 65-73 yr) than their younger (aged 25-35 yr) counterparts. Priming may not be a safe approach in elderly patients.